| Bioactivity | Golotimod (SCV-07), an immunomodulating peptide with antimicrobial activity, significantly increases the efficacy of antituberculosis therapy, stimulates thymic and splenic cell proliferation, and improves macrophage function. Golotimod (SCV-07) inhibits STAT3 signaling and modulates the duration and severity of oral mucositis in animal models that received radiation or a combination of radiation and Cisplatin. Golotimod (SCV-07) is also a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2)[1][2][3]. |
| Name | Golotimod |
| CAS | 229305-39-9 |
| Formula | C16H19N3O5 |
| Molar Mass | 333.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
Golotimod
CAS: 229305-39-9 F: C16H19N3O5 W: 333.34
Golotimod (SCV-07), an immunomodulating peptide with antimicrobial activity, significantly increases the efficacy of ant
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.